Geneos Wealth Management’s Affirm AFRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$764K Sell
9,372
-884
-9% -$57.8K 0.02% 611
2026
Q1
$470K Buy
10,256
+2,000
+24% +$116K 0.01% 715
2025
Q4
$614K Buy
8,256
+1,500
+22% +$108K 0.02% 609
2025
Q3
$494K Sell
6,756
-63
-0.9% -$4.79K 0.01% 653
2025
Q2
$471K Buy
6,819
+6,668
+4,416% +$346K 0.01% 729
2025
Q1
$6.82K Sell
151
-374
-71% -$22.2K ﹤0.01% 2407
2024
Q4
$32K Buy
525
+410
+357% +$22.8K ﹤0.01% 1514
2024
Q3
$4.69K Hold
115
– – ﹤0.01% 2089
2024
Q2
$3.47K Hold
115
– – ﹤0.01% 1791
2024
Q1
$4.29K Hold
115
– – ﹤0.01% 1741
2023
Q4
$5.65K Hold
115
– – ﹤0.01% 1698
2023
Q3
$2.45K Hold
115
– – ﹤0.01% 1903
2023
Q2
$1.76K Hold
115
– – ﹤0.01% 1946
2023
Q1
$1.3K Hold
115
– – ﹤0.01% 1965
2022
Q4
$1.11K Hold
115
– – ﹤0.01% 1949
2022
Q3
$2K Sell
115
-300
-72% -$7.85K ﹤0.01% 1819
2022
Q2
$7K Buy
415
+40
+11% +$1.09K ﹤0.01% 2065
2022
Q1
$17K Hold
375
– – ﹤0.01% 1869
2021
Q4
$37K Buy
375
+275
+275% +$36.3K ﹤0.01% 1612
2021
Q3
$11K Hold
100
– – ﹤0.01% 2167
2021
Q2
$6K Hold
100
– – ﹤0.01% 2364
2021
Q1
$7K Buy
+100
New +$9.72K ﹤0.01% 2513

Other funds holding AFRM

Geneos Wealth Management's AFRM Position: Q2 2026 in Review

Geneos Wealth Management reduced its Affirm (AFRM) stake by 8.6% in Q2 2026, selling an estimated $57.8K and leaving 9,372 shares worth $764K. The position accounts for 0.02% of the portfolio, ranked #611.

Geneos Wealth Management first reported a position in AFRM in Q1 2021 and has held it in 22 quarters since. 661 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • Geneos Wealth Management held 9,372 shares of Affirm worth $764K as of Q2 2026.
  • Geneos Wealth Management sold 884 Affirm shares in Q2 2026, an estimated $57.8K.
  • Affirm made up 0.02% of Geneos Wealth Management's portfolio in Q2 2026, its #611 holding.
  • Geneos Wealth Management first reported a position in Affirm in Q1 2021 and has held it in 22 quarters since.
  • 661 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.